Full Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
Clinical Chemistry Clinical Chemistry and Laboratory Medicine ClinicaChimicaActa American Journal of Hematology Clinical Biochemistry Annals of Clinical Biochemistry Transfusion American Journal of Clinical Pathology Scandinavian Journal of Clinical and Laboratory Investigation.Transfusion (Impact Factor: 3.57). 06/2012; 52(6):e15-6. DOI: 10.1111/j.1537-2995.2010.03014.x
- Thyroid: official journal of the American Thyroid Association 07/2011; 21(7):693. DOI:10.1089/thy.2011.2107.ed2 · 3.84 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: As medical editors, we are faced with a host of ethical dilemmas on a daily basis. Most are recognised and dealt with expediently, but the few that remain must be challenged as a cohesive body of editorial opinion.Head & Neck Oncology 01/2012; 4(2):42. · 3.14 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: BACKGROUND:Testosterone measurements that are accurate, reliable, and comparable across methodologies are crucial to improving public health. Current US Food and Drug Administration-cleared testosterone assays have important limitations. We sought to develop assay performance requirements on the basis of biological variation that allow physiologic changes to be distinguished from assay analytical errors.METHODS:From literature review, the technical advisory subcommittee of the Partnership for the Accurate Testing of Hormones compiled a database of articles regarding analytical and biological variability of testosterone. These data, mostly from direct immunoassay-based methodologies, were used to specify analytical performance goals derived from within- and between-person variability of testosterone.RESULTS:The allowable limits of desirable imprecision and bias on the basis of currently available biological variation data were 5.3% and 6.4%, respectively. The total error goal was 16.7%. From recent College of American Pathologists proficiency survey data, most currently available testosterone assays missed these analytical performance goals by wide margins. Data from the recently established CDC Hormone Standardization program showed that although the overall mean bias of selected certified assays was within 6.4%, individual sample measurements could show large variability in terms of precision, bias, and total error.CONCLUSIONS:Because accurate measurement of testosterone across a wide range of concentrations [approximately 2-2000 ng/dL (0.069-69.4 nmol/L)] is important, we recommend using available data on biological variation to calculate performance criteria across the full range of expected values. Additional studies should be conducted to obtain biological variation data on testosterone from women and children, and revisions should be made to the analytical goals for these patient populations.Clinical Chemistry 10/2012; 58(12). DOI:10.1373/clinchem.2012.186569 · 7.77 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.